Pfizer Stock: Paying Too Much To Boost Revenues (NYSE:PFE)

[ad_1]

Businesswoman handshake and business people. Successful business concept.

nathaphat

Thesis

I was initially interested in buying Pfizer (NYSE:PFE) but after deeper research, I got more and more reluctant to pull the trigger. So I am rating it a ‘Neutral/Hold’ for now. Here’s my narrative for Pfizer:

  1. Pfizer needs

[ad_2]
Source link

Leave a Reply

Your email address will not be published. Required fields are marked *